Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A04AD12	APREPITANT BIOGARAN 125MG APREPITANT BIOGARAN 80MG	G	Aprepitant - 125mg, Aprepitant - 80mg	125mg	Capsule	3,246,723 L.L
L04AA32	APRIVA	G	Apremilast - 30mg	30mg	Tablet, film coated	41,455,526 L.L
L04AA32	APRIVA STARTER PACK	G	Apremilast - 10mg, Apremilast - 20mg, Apremilast - 30mg		Tablet, film coated	22,154,866 L.L
C09CA04	APROVEL	B	Irbesartan - 150mg	150mg	Tablet, film coated	651,764 L.L
C09CA04	APROVEL	B	Irbesartan - 150mg	150mg	Tablet, film coated	651,764 L.L
C09CA04	APROVEL	B	Irbesartan - 300mg	300mg	Tablet, film coated	651,764 L.L
C09CA04	APROVEL	B	Irbesartan - 300mg	300mg	Tablet, film coated	651,764 L.L
M01AB16	ARACENAC	G	Aceclofenac - 100mg	100mg	Tablet, film coated	330,585 L.L
J06BA02	ARAGAM	BioHuman	Human normal immunoglobulin - 5g/100ml	5g/100ml	Injectable solution	40,075,575 L.L
A02BC01	ARAPRIDE	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	427,342 L.L
J01FA10	ARATRO	G	Azithromycin - 200mg/5ml	200mg/5ml	Powder for suspension	765,990 L.L
J01FA10	ARATRO	G	Azithromycin - 200mg/5ml	200mg/5ml	Powder for suspension	403,153 L.L
J01FA10	ARATRO	G	Azithromycin - 500mg	500mg	Tablet, film coated	485,127 L.L
L04AA13	ARAVA	B	Leflunomide - 10mg	10mg	Tablet, film coated	2,230,779 L.L
L04AA13	ARAVA	B	Leflunomide - 20mg	20mg	Tablet, film coated	3,346,168 L.L
C09CA03	ARBITEN 160	G	Valsartan - 160mg	160mg	Tablet	544,256 L.L
C09CA03	ARBITEN 80	G	Valsartan - 80mg	80mg	Tablet	387,027 L.L
C09DB01	ARBITEN AM 10/160	G	Amlodipine - 10mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L
C09DB01	ARBITEN AM 5/160	G	Amlodipine - 5mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L
C09DX01	ARBITEN AM PLUS	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	857,372 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet	544,256 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 25mg		Tablet	579,196 L.L
C09CA07	ARBIVASTEL	G	Telmisartan - 80mg	80mg	Tablet	667,890 L.L
J01DH02	ARCHIFAR	G	Meropenem - 500mg	500mg	Injectable powder for solution	6,443,725 L.L
J01DH02	ARCHIFAR	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 60mg	60mg	Tablet, film coated	1,685,178 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 90mg	90mg	Tablet, film coated	2,119,240 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 120mg	120mg	Tablet, film coated	603,385 L.L
M01AE03	ARDBEG 80MG ADULTS	G	Ketoprofen Lysine salt - 80mg	80mg	Powder for solution	634,294 L.L
J01CR02	ARDINECLAV	G	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Tablet	431,309 L.L

...

187